Back
Header image

Transforming Global Genetic Data into Medical Decisions

Our goal is the rapid medical diagnosis of inherited diseases, provided at the earliest possible moment as we turn analytical information into actionable results for physicians, patients and pharmaceutical partners.

Our commitment to the global medical community is an early and precise diagnosis for continuous improvement of therapeutic options for each individual patient.

Latest Scientific News

Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian…

CENTOGENE considers its global positioning a key aspect for generating truly novel…

Article with topic Nephrology and endocrinology
Read more

A homozygous frameshift variant in an alternatively spliced exon of DLG5…

Based on the ambition to provide maximum diagnostic yield, CENTOGENE offers follow up of…

Article with topic WES, WGS, Neurology
Read more

Assessment of Cardiac Involvement in Fabry Disease (FD) with Native T1…

Mass-spectrometry based quantification of biomarkers is a routine step in the diagnostic…

Article with topic Metabolism, Cardiology, Biomarker
Read more

Prodromal substantia nigra sonography undermines suggested association…

Parkinson’s disease (PD) and Gaucher disease are amongst the primary research foci at…

Article with topic Neurology, Biomarker
Read more

Customer Feedback

Give feedback

Newsletter subscription

CENTOGENE Appoints AI Industry Leader Dr. Carsten Ullrich as Director of Artificial Intelligence

Research Fellow from German Research Center for Artificial Intelligence to lead team driving solutions for pharmaceutical partners.

 Read more
Centogene,

CentoMetabolic™ Panel for Integrated Multiomic Testing for Metabolic Diseases

Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions.

 Read more
Centogene,

CENTOGENE announces the appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman

Rostock/Berlin, Germany, 2 April, 2019 – CENTOGENE announced today that Dr. Flemming Ornskov has been appointed to the Supervisory Board and has been elected...

 Read more
Centogene,

Digitization in Mecklenburg-Vorpommern

As part of an exchange with senior business and academic leaders, and state of Mecklenburg-Vorpommern (M-V) government representatives, a discussion and...

 Read more
Centogene,

CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics

Agreement focused on identification of patients with Duchenne muscular dystrophy (DMD)

 Read more
Centogene,

New Validation Framework to Optimize Specificity and Sensitivity in WES-Based Diagnostics

CENTOGENE, a rare disease company committed to improving the lives of rare disease patients by providing solutions that accelerate the development of drugs, has...

 Read more
Centogene,

CENTOGENE Expands Clinical Studies Team in U.S.

Driving Pharmaceutical Partnerships and Accelerating Orphan Drug Development

 Read more
Centogene,

CENTOGENE Receives Prestigious Re-Accreditation by College of American Pathologists

CENTOGENE’s state-of-the-art genetic laboratory facilities in Rostock, Germany awarded accreditation for the fourth year

 Read more
Centogene,

CENTOGENE Corporate and Business Unit Update 2018

2018 highlights include expansion to U.S., new partnerships with leading pharmaceutical companies, and growth of diagnostic testing portfolio for rare diseases...

 Read more
Centogene,